Targeted therapy for melanoma: rational combinatorial approaches.

Area of Science:

• Oncology
• Dermatology
• Molecular Biology

Background:

• Melanoma is an aggressive skin cancer.
• Personalized targeted therapies have revolutionized melanoma treatment.
• BRAF and MEK inhibitors show clinical efficacy in selected patients.

Purpose of the Study:

• To review preclinical and clinical studies on combinatorial targeted therapy for melanoma.
• To discuss emerging strategies for overcoming resistance to targeted therapies.
• To highlight future directions in melanoma treatment.

Main Methods:

• Review of existing preclinical and clinical studies.
• Analysis of molecular heterogeneity in melanoma.
• Identification of resistance mechanisms to targeted therapies.

Main Results:

• Targeted therapies like BRAF and MEK inhibitors offer significant clinical benefits.
• Molecular heterogeneity and resistance mechanisms necessitate combination strategies.
• Various combinatorial approaches are under investigation.

Conclusions:

• Combinatorial targeted therapy holds significant promise for future melanoma treatment.
• Understanding resistance mechanisms is crucial for developing effective combination strategies.
• Further research is needed to optimize these approaches for improved patient outcomes.